(Q37639896)

21 August 2017

1 reference

title

Histological and molecular types of breast cancer: is there a unifying taxonomy? (English)

1 reference

21 August 2017

1 reference

2

Jorge S Reis-Filho

1 reference

21 August 2017

1

Britta Weigelt

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Nature Reviews Clinical Oncology

21 August 2017

published in

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

718-730

1 reference

Breast cancer special types: why bother?

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Molecular evolution of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Modelling breast cancer: one size does not fit all.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Molecular portraits of human breast tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Repeated observation of breast tumor subtypes in independent gene expression data sets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

The molecular portraits of breast tumors are conserved across microarray platforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

A gene-expression signature as a predictor of survival in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Gene expression profiling predicts clinical outcome of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Identification of molecular apocrine breast tumours by microarray analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Polymorphous adenocarcinoma of the breast. Report of three cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

On the origin and progression of ductal carcinoma in the human breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Genomic signatures to guide the use of chemotherapeutics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Molecular subtypes in breast cancer evaluation and management: divide and conquer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Do 'basal-like' breast cancers really exist?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Supervised risk predictor of breast cancer based on intrinsic subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Refinement of breast cancer classification by molecular characterization of histological special types

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Metaplastic breast carcinomas are basal-like tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Breast cancer, stem/progenitor cells and the estrogen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Will cancer stem cells provide new therapeutic targets?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

A mouse model of basal-like breast carcinoma with metaplastic elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Breast cancer: origins and evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

ETV6 gene rearrangements in invasive breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Carcinomas with micropapillary morphology: clinical significance and current concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

In situ and invasive lobular neoplasia of the breast.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Epigenetic and genetic alterations ofAPCandCDH1genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

BRCA1 dysfunction in sporadic basal-like breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Basal-like breast cancer and the BRCA1 phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Biphasic metaplastic sarcomatoid carcinoma of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

Concordance among gene-expression-based predictors for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.166

An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions

31 March 2020

1 reference

12 December 2020

Classification of metaplastic carcinomas of the breast

1 reference

12 December 2020

Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases

1 reference

12 December 2020

Metaplastic breast carcinoma. Rare form of mammary cancer

1 reference

12 December 2020

[Histological classification of breast cancer. 2]

1 reference

12 December 2020

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

1 reference

12 December 2020

[Histological classification of breast cancer]

1 reference

12 December 2020

Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer

1 reference

12 December 2020

Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis

1 reference

12 December 2020

Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations

1 reference

12 December 2020

10.1038/NRCLINONC.2009.166

Identifiers

DOI

1 reference

21 August 2017

1 reference